暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股市场个股详情
OII 国际海洋工程
- 22.890
- +0.370+1.64%
收盘价 05/03 16:00 (美东)
- 23.090
- +0.200+0.87%
盘后 19:28 (美东)
23.21亿总市值21.59市盈率TTM
23.410最高价22.580最低价97.22万股成交量22.860今开22.520昨收2234.71万成交额0.98%换手率24.09市盈率(静)1.01亿总股本27.46052周最高3.72市净率22.82亿流通值14.99052周最低--股息TTM9970.63万流通股79.892历史最高--股息率TTM3.69%振幅1.929历史最低22.985平均价1股每手
全部分时
- 5日
- 日K
- 周K
- 月K
- 季K
- 年K
资金分布
单位: --
资金流向
实时日周月
暂无数据
新闻
评论
The modest level of insider ownership and lack of insider transactions in the last three months suggest alignment with shareholder interests. However, significant insider selling over the past year could be a red flag for investors.
Insiders At Oceaneering International Sold US$2.5m In Stock, Alluding To Potential WeaknessOceaneering International, Inc.'s transition from loss to profitability justifies its strong share price gain. Despite slowing gains, the company's future financial health remains crucial for shareholders.
Oceaneering International's respectable ROE is overshadowed by its high debt level. Investors should consider the company's performance potential in less favorable credit markets. High ROE without debt typically indicates a high-quality business.
$国际海洋工程(OII.US$营收5年来变化不大，营业利润则在2018到2020年连续亏损3年，仅2017和2021年盈利，净利润则在近4年连续亏损，2022前三季度仅微弱盈利。目前看不到投资价值。
专栏Today's pre-market stock movers: DOCU, BGNE, RBLX, SFIX and more
Gainers:
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $百济神州(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
• $Cogent Biosciences(COGT.US$ +7.9% (announces positive initial clinical data from ongoing phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis)
• $Univar Solutions(UNVR.US$ +7.2% (expands distribution partnership with BASF)
• $Vail Resorts(MTN.US$ +6% (In reaction to earnings/guidance)
• $百济神州(BGNE.US$ +5.4% (highlights growing portfolio and pipeline targeting hematologic mali...
17
7
阅读更多
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅